Patents by Inventor Jens Schwamborn

Jens Schwamborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11976296
    Abstract: The present invention provides means and methods for the generation of midbrain organoids which are useful for studying neurodevelopmental and neurodegenerative diseases. Neuroepithelial stem cells serve as a starting population for the generation of midbrain organoids by contacting them with differentiation medium under agitating conditions in three-dimensional cell culture comprising a matrix.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: May 7, 2024
    Assignee: UNIVERSITÉ DU LUXEMBOURG
    Inventors: Silvia Bolognin, Anna Monzel, Jens Schwamborn
  • Publication number: 20230167391
    Abstract: The present invention relates to a microfluidic device (1) for cultivating cells, in particular for generating brain organoids, comprising at least two fluid channels (2) positioned essentially opposite to each other and a main chamber (3) located between the fluid channels (2), wherein the main chamber (3) comprises at least one preferably sealable access opening, and each of the at least two fluid channels (2) is fluidly connected to the main chamber (3) at at least one point of contact (4), wherein a slotted structure (5) is provided at each point of contact (4) separating the main chamber (3) from the respective fluid channel (2), wherein the slotted structure (5) is permeable to a liquid.
    Type: Application
    Filed: May 5, 2021
    Publication date: June 1, 2023
    Inventors: Sarah SPITZ, Peter ERTL, Jens SCHWAMBORN, Silvia BOLOGNIN
  • Publication number: 20200341017
    Abstract: The present invention relates to a method for identifying molecules promoting or inhibiting dopaminergic neuronal differentiation and/or death of dopaminergic neurons in a three-dimensional cell culture. Furthermore, the present invention relates to a method for producing dopaminergic neurons in a three-dimensional cell culture. In addition, the present invention relates to a method for segmenting an image of a cell culture.
    Type: Application
    Filed: October 22, 2018
    Publication date: October 29, 2020
    Inventors: Silvia Bolognin, Marie Fossepre, Paul Antony, Jens Schwamborn
  • Publication number: 20200165635
    Abstract: The present invention relates to a nucleic acid molecule at least one nucleotide sequence encoding a selection marker indicating homologous recombination in a eukaryotic cell and at least one nucleotide sequence encoding a selection marker indicating heterologous recombination in said eukaryotic cell. The present invention also relates to a composition of matter comprising at least two nucleic acid molecules of the invention. The present invention further relates to in vitro methods for enriching or producing eukaryotic cells which are modified by homologous recombination.
    Type: Application
    Filed: January 30, 2017
    Publication date: May 28, 2020
    Inventors: Jonathan Arias FUENZALIDA, Javier JARAZO, Jens SCHWAMBORN, Xiaobing QING
  • Publication number: 20180298330
    Abstract: The present invention provides means and methods for the generation of midbrain organoids which are useful for studying neurodevelopmental and neurodegenerative diseases. Neuroepithelial stem cells serve as a starting population for the generation of midbrain organoids by contacting them with differentiation medium under agitating conditions in three-dimensional cell culture comprising a matrix.
    Type: Application
    Filed: October 10, 2016
    Publication date: October 18, 2018
    Inventors: Silvia BOLOGNIN, Anna MONZEL, Jens SCHWAMBORN
  • Patent number: 8431398
    Abstract: Modulators of TRIM-NHL proteins and their use for modulating the proliferation and differentiation potential of stem cells and progenitor cells. Inhibitors of TRIM-NHL proteins, e.g. TRIM32, are useful for stem cell maintenance in vitro and in vivo. Assay methods for identifying TRIM-NHL protein modulators make use of the E3 ligase activity of TRIM32 or its interaction with Argonaute-1.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: April 30, 2013
    Assignee: IMBA-Institut fur Molekulare Biotechnologie GmbH
    Inventors: Juergen Knoblich, Jens Schwamborn
  • Publication number: 20100317563
    Abstract: Modulators of TRIM-NHL proteins and their use for modulating the proliferation and differentiation potential of stem cells and progenitor cells. Inhibitors of TRIM-NHL proteins, e.g. TRIM32, are useful for stem cell maintenance in vitro and in vivo. Assay methods for identifying TRIM-NHL protein modulators make use of the E3 ligase activity of TRIM32 or its interaction with Argonaute-1.
    Type: Application
    Filed: September 19, 2008
    Publication date: December 16, 2010
    Applicant: IMBA-INSTITUT FUR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Juergen Knoblich, Jens Schwamborn